Skip to main content
. 2021 Dec 16;12:780769. doi: 10.3389/fendo.2021.780769

Figure 2.

Figure 2

(A–C) ROC analysis were performed to evaluate the ability of HDL-C in predicting EC patient prognosis at 1-, 3-, and 5-years. (D) A nomogram was constructed based on HDL-C, grade, and stage to predict 1- and 3-year survival rates of EC patients. (E, F) Calibration curve analysis and DCA analysis of the nomogram.